Drug intelligence / Profile preview

methyltestosterone

Development stage
Approved
Lead developer
Axplora
Modality
Small Molecules
Administration
Oral, Buccal
01

Overview

Methyltestosterone is a synthetic, orally active androgen and anabolic steroid (AAS). It is a 17α-methylated derivative of testosterone, which enhances its oral bioavailability by reducing first-pass hepatic metabolism. As an agonist of the androgen receptor (AR), it mimics the effects of endogenous testosterone, promoting the development of male secondary sexual characteristics and exerting anabolic effects on muscle and bone. It is primarily indicated for replacement therapy in males with primary or hypogonadotropic hypogonadism and for the stimulation of puberty in males with delayed onset. In females, it is used as a secondary treatment for advancing inoperable metastatic mammary cancer and, at lower doses, in combination with estrogens for menopausal vasomotor symptoms. Due to its 17α-alkylated structure, long-term use is associated with potential hepatotoxicity, including peliosis hepatis and hepatocellular carcinoma.

Brand names
AndroidMetandrenTestredVirilonAndroralOravironEnarmonTesto Tabs
Other names
17-alpha-methyltestosteronemethyl testosterone17α-methyltestosterone
02

Targets

AR (Adrenergic receptors)

Beyond the preview

Go deeper on methyltestosterone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methyltestosterone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call